Shaftesbury Capital PLC
LSE:SHC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Shaftesbury Capital PLC
LSE:SHC
|
UK |
|
Elevation Oncology Inc
NASDAQ:ELEV
|
US |
|
EchoStar Corp
NASDAQ:SATS
|
US |
|
S
|
SCI Pharmtech Inc
TWSE:4119
|
TW |
Wall Street
Price Targets
SHC Price Targets Summary
Shaftesbury Capital PLC
According to Wall Street analysts, the average 1-year price target for
SHC
is 173.31 GBX
with a low forecast of 136.35 GBX and a high forecast of 220.5 GBX.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is SHC's stock price target?
Price Target
173.31
GBX
According to Wall Street analysts, the average 1-year price target for
SHC
is 173.31 GBX
with a low forecast of 136.35 GBX and a high forecast of 220.5 GBX.
What is Shaftesbury Capital PLC's Revenue forecast?
Projected CAGR
0%
For the last 14 years the
compound annual growth rate for
Shaftesbury Capital PLC's revenue is
6%.
The projected
CAGR
for the next 3 years is
0%.
What is Shaftesbury Capital PLC's Operating Income forecast?
Projected CAGR
7%
For the last 14 years the
compound annual growth rate for
Shaftesbury Capital PLC's operating income is
9%.
The projected
CAGR
for the next 3 years is
7%.
What is Shaftesbury Capital PLC's Net Income forecast?
Projected CAGR
-31%
For the last 14 years the
compound annual growth rate for
Shaftesbury Capital PLC's net income is
6%.
The projected
CAGR
for the next 3 years is
-31%.
